PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in developing new molecular imaging agents for early detection of neurological disorders, today announced the addition of Ernest Mario, Ph.D. to its Board of Directors. Dr. Mario brings to Avid over 35 years of experience in the pharmaceutical, medical device and biotechnology fields and will provide his strategic expertise as Avid RP advances its clinical pipeline.
